Matches in Wikidata for { <http://www.wikidata.org/entity/Q37026564> ?p ?o ?g. }
- Q37026564 description "article científic" @default.
- Q37026564 description "article scientifique" @default.
- Q37026564 description "articolo scientifico" @default.
- Q37026564 description "artigo científico" @default.
- Q37026564 description "artículu científicu espublizáu en 2013" @default.
- Q37026564 description "bilimsel makale" @default.
- Q37026564 description "scientific article published on 09 April 2013" @default.
- Q37026564 description "vedecký článok" @default.
- Q37026564 description "vetenskaplig artikel" @default.
- Q37026564 description "videnskabelig artikel" @default.
- Q37026564 description "vědecký článek" @default.
- Q37026564 description "wetenschappelijk artikel" @default.
- Q37026564 description "wissenschaftlicher Artikel" @default.
- Q37026564 description "наукова стаття, опублікована у квітні 2013" @default.
- Q37026564 description "научни чланак" @default.
- Q37026564 description "مقالة علمية نشرت في 09 أبريل 2013" @default.
- Q37026564 name "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 name "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 name "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 type Item @default.
- Q37026564 label "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 label "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 label "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 prefLabel "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 prefLabel "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 prefLabel "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.
- Q37026564 P1433 Q37026564-19715465-4325-4EE6-8338-ACA19429AB8D @default.
- Q37026564 P1476 Q37026564-B74CCC52-26B8-4C6A-942B-A2D68187A949 @default.
- Q37026564 P2093 Q37026564-11CE7B2F-0902-45EA-A52B-C0C315AFCAA6 @default.
- Q37026564 P2093 Q37026564-189A8A1C-17EF-45AF-A4B5-61C54650BD1D @default.
- Q37026564 P2093 Q37026564-391FED13-97D6-429F-90EB-448DD5FDE21A @default.
- Q37026564 P2093 Q37026564-45917BEB-485D-4F78-A435-C6B9384579E8 @default.
- Q37026564 P2093 Q37026564-4C0FBAFB-D3E5-420F-A92F-9F88A15A93E5 @default.
- Q37026564 P2093 Q37026564-4EEBA015-8416-4123-A081-C08EEAB55DA7 @default.
- Q37026564 P2093 Q37026564-5AB1A5D5-51B5-49AD-9658-77A733EC4013 @default.
- Q37026564 P2093 Q37026564-7A59CCA4-0CA8-46CF-8B5B-F7D16389130F @default.
- Q37026564 P2093 Q37026564-96DB1099-8C80-4E77-969C-E0F67B31C035 @default.
- Q37026564 P2093 Q37026564-A44720C5-DD97-4246-B257-865D481CD15C @default.
- Q37026564 P2093 Q37026564-A52F102E-F9CA-4624-A487-577F06369947 @default.
- Q37026564 P2093 Q37026564-AD89A2AC-3132-4C73-8555-07D23CB1BCD2 @default.
- Q37026564 P2093 Q37026564-C693839C-8756-4481-95D9-74686ADA5897 @default.
- Q37026564 P2093 Q37026564-F15FD23F-8A92-40A1-B36E-75F660039A3A @default.
- Q37026564 P2093 Q37026564-F97053C4-5B22-4BEC-A34A-AD7D1F6AACBE @default.
- Q37026564 P2860 Q37026564-03C97951-01E4-4404-BEC4-24BDE5BA5E99 @default.
- Q37026564 P2860 Q37026564-0E47EFCF-4539-4888-B50B-BEA38B5066AC @default.
- Q37026564 P2860 Q37026564-1247D974-B2FC-474E-A7B9-CA645EFC989E @default.
- Q37026564 P2860 Q37026564-12F9E548-5E8B-4E1B-97FE-7EC8DE468B0A @default.
- Q37026564 P2860 Q37026564-14EE9035-66B2-4EF9-9549-D36C9D6692C7 @default.
- Q37026564 P2860 Q37026564-1910328A-F9E3-49E3-8FFF-EC0B88E8F30A @default.
- Q37026564 P2860 Q37026564-2157D000-AE5F-4742-BE22-3FABB887293F @default.
- Q37026564 P2860 Q37026564-2FDB1BA9-55C5-4876-ADD2-A9480668C4FE @default.
- Q37026564 P2860 Q37026564-3BF2EA8F-3FDE-4ECE-9362-1DE65A9E6096 @default.
- Q37026564 P2860 Q37026564-3E646383-1A63-456D-AE17-41F4EAFFA684 @default.
- Q37026564 P2860 Q37026564-40573200-6050-48CA-BD68-5697C7B114FB @default.
- Q37026564 P2860 Q37026564-4A3CE904-8423-4E99-9677-F018C893542E @default.
- Q37026564 P2860 Q37026564-5173FA3A-E2DB-4D0E-8CAD-861718A2844F @default.
- Q37026564 P2860 Q37026564-58C91C4F-F691-42DF-A329-2F2B86C6DC01 @default.
- Q37026564 P2860 Q37026564-59726C0E-2F18-404E-93B2-F88CF59070E8 @default.
- Q37026564 P2860 Q37026564-597F4E3E-C695-44A6-B2DB-D99D092D5C54 @default.
- Q37026564 P2860 Q37026564-5A19C995-6D02-4342-AC8D-4D23CF4F328A @default.
- Q37026564 P2860 Q37026564-5C265287-ABCF-4D90-B67B-5E0AB53A9D31 @default.
- Q37026564 P2860 Q37026564-5CE8FD51-A140-43CA-8B53-7248E98877D1 @default.
- Q37026564 P2860 Q37026564-628ECC16-EEB8-47B6-8325-DE14E5EF1076 @default.
- Q37026564 P2860 Q37026564-71225925-33B0-49F9-A63A-6C1ADC0E5EB3 @default.
- Q37026564 P2860 Q37026564-7136F7A2-A470-44F6-8D8F-5D76230738B0 @default.
- Q37026564 P2860 Q37026564-71C5B613-9A45-4DF5-8B61-6503A8D7CE96 @default.
- Q37026564 P2860 Q37026564-82A040D5-F6EB-4886-84EA-BDA7EADD1A90 @default.
- Q37026564 P2860 Q37026564-8910834C-EDA9-4629-8F56-3A803CB7E911 @default.
- Q37026564 P2860 Q37026564-99F1B382-CF50-4C69-B284-8991029EC4DD @default.
- Q37026564 P2860 Q37026564-A6F743DE-95DE-4309-8536-09817B1CB01A @default.
- Q37026564 P2860 Q37026564-AEBFE878-25BB-468F-AF75-5160D741B15B @default.
- Q37026564 P2860 Q37026564-B79263C2-1B74-4166-8022-14103515F914 @default.
- Q37026564 P2860 Q37026564-C0172B36-F26A-4864-8B96-2AAA63F5F4F4 @default.
- Q37026564 P2860 Q37026564-C3047110-4315-483E-AD0A-8459B75A896D @default.
- Q37026564 P2860 Q37026564-C5C2C1C5-46AA-4990-AA65-2569C59AB332 @default.
- Q37026564 P2860 Q37026564-C7520622-15FB-4EA8-9E35-DCB83F27838E @default.
- Q37026564 P2860 Q37026564-D2A1EAAB-1A7C-4D31-91BF-52EFFCF6A386 @default.
- Q37026564 P2860 Q37026564-DB43D223-41A6-4C2F-95F3-0C1B26108CA6 @default.
- Q37026564 P2860 Q37026564-E430A541-A586-4D44-ADDF-54E645EE060D @default.
- Q37026564 P2860 Q37026564-F1CC6467-28A7-4145-9882-FC7FF1D03691 @default.
- Q37026564 P2860 Q37026564-FBDA9038-D15B-42C0-81D5-031FE1755797 @default.
- Q37026564 P2860 Q37026564-FD1D11C2-9AB4-4B6C-AF0A-A4136B5B4373 @default.
- Q37026564 P304 Q37026564-8E1816BF-5FA8-4DF8-9087-AC38F01661EC @default.
- Q37026564 P31 Q37026564-1568762F-7F53-4542-82AA-CA376839D9C9 @default.
- Q37026564 P356 Q37026564-A84284CD-9593-4AFA-B17F-3657C1BDA5AC @default.
- Q37026564 P407 Q37026564-F2FD5CA6-5E30-4D66-BF36-72E3E540227A @default.
- Q37026564 P433 Q37026564-87B0DE9D-F92F-403E-8EAA-6CE571DF3032 @default.
- Q37026564 P478 Q37026564-86A5D4A0-2ADC-47D4-AC5C-CBB2CA721D02 @default.
- Q37026564 P50 Q37026564-ADA7A9C1-8289-483E-8CA5-49C5EC0231AA @default.
- Q37026564 P50 Q37026564-B46943B6-89F7-412D-AE13-E464339C128A @default.
- Q37026564 P577 Q37026564-543BF331-F5CB-45BD-BDE1-153661A2FF92 @default.
- Q37026564 P698 Q37026564-A2C885E6-AAD4-48F9-9196-B07B3648BCAD @default.
- Q37026564 P8608 Q37026564-3D58ADCB-48AA-49B5-9B6F-D079D0F70AF6 @default.
- Q37026564 P921 Q37026564-1342839B-D208-40C1-B6B1-D5000EC250CB @default.
- Q37026564 P921 Q37026564-43305ECB-60AE-4FBE-9C83-91CE2748B493 @default.
- Q37026564 P932 Q37026564-A66982AD-6531-413C-AE2C-D82FA77332E2 @default.
- Q37026564 P356 AAC.00405-13 @default.
- Q37026564 P698 23571535 @default.
- Q37026564 P1433 Q578004 @default.
- Q37026564 P1476 "Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy" @default.